Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Merad

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Nature Biotechnology|June 13, 2022
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCRMegan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, et al.
Nature Immunology|April 30, 2013
Identification of transcriptional regulators in the mouse immune systemVladimir Jojic, Tal Shay, Katelyn Sylvia, et al.
Elife|December 6, 2017
The Human Cell AtlasAviv Regev, Sarah A Teichmann, Eric S Lander, et al.
Gastroenterology|March 7, 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Nature Medicine|February 22, 2022
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activityMathieu Uzzan, Jerome C Martin, Luka Mesin, et al.
Nature Medicine|July 29, 2020
Sampling the host response to SARS-CoV-2 in hospitals under siegeAlexander W Charney, Nicole W Simons, Konstantinos Mouskas, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Clinical Proteomics|September 28, 2022
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individualsGuillaume Butler-Laporte, Edgar Gonzalez-Kozlova, Chen-Yang Su, et al.
Nature Immunology|May 7, 2013
The transcriptional landscape of αβ T cell differentiationMichael Mingueneau, Taras Kreslavsky, Daniel Gray, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Nature Biotechnology|June 13, 2022
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCRMegan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, et al.
Nature Immunology|April 30, 2013
Identification of transcriptional regulators in the mouse immune systemVladimir Jojic, Tal Shay, Katelyn Sylvia, et al.
Elife|December 6, 2017
The Human Cell AtlasAviv Regev, Sarah A Teichmann, Eric S Lander, et al.
Gastroenterology|March 7, 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Nature Medicine|February 22, 2022
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activityMathieu Uzzan, Jerome C Martin, Luka Mesin, et al.
Nature Medicine|July 29, 2020
Sampling the host response to SARS-CoV-2 in hospitals under siegeAlexander W Charney, Nicole W Simons, Konstantinos Mouskas, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Clinical Proteomics|September 28, 2022
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individualsGuillaume Butler-Laporte, Edgar Gonzalez-Kozlova, Chen-Yang Su, et al.
Nature Immunology|May 7, 2013
The transcriptional landscape of αβ T cell differentiationMichael Mingueneau, Taras Kreslavsky, Daniel Gray, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Pageof 35